AHC.AU Austco Healthcare Ltd
- Market cap
- AUD 105M
- P/E
- 14.0x
- P/B
- 1.69x
- ROE
- 14.5%
- Dividend yield
- -
- Fundamental score
- 3.4/5
Ratios use the latest price and the fiscal year ending Jun 2026.
Is AHC.AU undervalued?
Graham numberAHC.AU trades 2.5% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Austco Healthcare Ltd fundamental analysis
16 of 22 checks passedROE 1/2
Moderate return on equity (14.5%), between 10% and 20%.
ROA 1/1
Return on assets (10.2%) is above the industry median (-35.3%).
Profit Consistency 2/2
Profitable for 9 consecutive years.
Earnings Growth 5Y 1/1
Earnings per share grew over the past 5 years.
Earnings Acceleration 1/1
Last year's EPS growth (48.9%) is above the 5-year average (14.7% a year).
Earnings Growth vs Industry 1/1
Last year's EPS growth (48.9%) is above the industry median (24.9%).
Revenue Growth 2/2
Revenue grew 30.9% a year over the past 3 years.
Short-term Liquidity 1/1
Current assets cover short-term liabilities.
Long-term Liabilities 1/1
Current assets cover long-term liabilities.
Debt to Equity 2/2
Low debt to equity (6.4%), 40% or less.
Debt Trend 0/1
Debt to equity has risen over the past 5 years.
Debt Coverage 1/1
Operating cash flow covers 20% of total debt.
Interest Coverage 1/1
EBIT is 27.8x against interest expense, well covered.
PE vs Market 1/1
PE (14.0x) is below the market median (15.0x).
PE vs Industry 1/1
PE (14.0x) is below the industry median (36.4x).
PBV 1/1
Price to book (1.7x) is below the industry median (4.0x).
Graham Number 0/1
The price is above the Graham number (PE x PB = 23.6, limit 22.5).
PEG 1/1
PEG on 5-year earnings growth is 0.95, growth is cheap.
Dividend Yield 0/2
No dividend paid in the last reported year.
Dividend Stability 0/2
Dividends were not paid steadily for the past 5 years.
Dividend Growth 0/1
Dividends paid did not grow over the past 5 years.
Payout Ratio 0/1
No dividend, or no profit to pay it from.
Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score
Austco Healthcare Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Austco Healthcare Ltd
Austco Healthcare Limited, together with its subsidiaries, engages in the business of development, manufacture, service, supply, and distribution of healthcare communications equipment and software in Australia, New Zealand, Asia, Europe, and North America. The company offers Tacera, an IP nurse call system; Medicom, a solution for nurse call system; Pulse Mobile which allows staff to manage nurse call functions on the go and trigger workflows remotely; clinical workflow tha…
Full company profileAustco Healthcare Ltd financial statements
Austco Healthcare Ltd annual financial statements (AUD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 29.0M | 29.0M | 31.7M | 31.6M | 31.3M | 35.9M | 42.0M | 58.2M | 81.4M | 94.2M |
| Gross Profit | 13.3M | 14.2M | 14.5M | 16.4M | 16.7M | 18.8M | 6.68M | 30.7M | 42.4M | 21.0M |
| Operating Income | -1.45M | 1.31M | 120K | 2.74M | 2.08M | 1.81M | 1.80M | 5.79M | 10.9M | 10.8M |
| EBITDA | -3.68M | 1.58M | 558K | 3.65M | 5.01M | 3.73M | 3.60M | 8.11M | 13.5M | 14.8M |
| Net Income | -6.42M | 1.19M | 637K | 2.50M | 3.42M | 2.33M | 2.26M | 7.08M | 5.93M | 9.01M |
| EPS | -0.03 | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 |
| Balance Sheet | ||||||||||
| Total Assets | 17.4M | 16.8M | 19.7M | 23.1M | 27.2M | 34.0M | 37.9M | 68.7M | 91.1M | 88.5M |
| Total Liabilities | 9.09M | 7.23M | 9.19M | 6.83M | 7.89M | 10.9M | 12.9M | 24.3M | 39.3M | 26.4M |
| Shareholders' Equity | 8.26M | 9.58M | 10.5M | 16.3M | 19.3M | 23.1M | 25.0M | 44.4M | 51.7M | 62.1M |
| Cash & Short-term Investments | 1.72M | 2.31M | 1.95M | 6.45M | 7.77M | 7.63M | 4.67M | 13.6M | 14.5M | 16.3M |
| Total Debt | 1.15M | 655K | 277K | 866K | 1.15M | 979K | 524K | 1.78M | 3.88M | 3.95M |
| Cash Flow | ||||||||||
| Operating Cash Flow | -2.55M | 2.03M | 1.42M | 3.30M | 3.21M | 1.94M | 320K | 11.3M | 13.4M | 12.5M |
| Capital Expenditure | 18.0K | 889K | 1.34M | 1.51M | 147K | 1.63M | 1.57M | 3.90M | 2.76M | 794K |
| Free Cash Flow | -2.57M | 1.14M | 81.0K | 1.79M | 3.06M | 315K | -1.25M | 7.45M | 10.7M | 11.7M |
| Ratios | ||||||||||
| ROE | -77.7% | 12.5% | 6.0% | 15.4% | 17.7% | 10.1% | 9.0% | 15.9% | 11.5% | 14.5% |
| ROA | -37.0% | 7.1% | 3.2% | 10.8% | 12.6% | 6.8% | 6.0% | 10.3% | 6.5% | 10.2% |
| Net Profit Margin | -22.2% | 4.1% | 2.0% | 7.9% | 11.0% | 6.5% | 5.4% | 12.2% | 7.3% | 9.6% |
| Debt to Equity | 0.14x | 0.07x | 0.03x | 0.05x | 0.06x | 0.04x | 0.02x | 0.04x | 0.08x | 0.06x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Austco Healthcare Ltd dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- Mar 2, 2023
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | - | - | - |
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | AUD 897K | 0.00 | 39.7% |
| 2022 | AUD 897K | 0.00 | 38.5% |
| 2021 | AUD 897K | 0.00 | 26.2% |
| 2020 | AUD 897K | 0.00 | 35.8% |
| 2019 | - | - | - |
| 2018 | - | - | - |
| 2017 | AUD 57.0K | 0.00 | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:1 on Feb 28, 1989.
Who owns Austco Healthcare Ltd
- Insiders 35.41%
- Institutions 16.61%
- Public & others 47.98%
- Shares outstanding 375M
- Free float 241M
Austco Healthcare Ltd company profile
- Company name
- Austco Healthcare Ltd
- Ticker
- AHC.AU
- ISIN
- AU0000120818
- Exchange
- Australian Securities Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Fiscal year end
- June
- Address
- 484 Graham Street, Port Melbourne, VIC, Australia, 3207
- Phone
- 61 3 9209 9688
- Website
- austcohealthcare.com
About Austco Healthcare Ltd
Austco Healthcare Limited, together with its subsidiaries, engages in the business of development, manufacture, service, supply, and distribution of healthcare communications equipment and software in Australia, New Zealand, Asia, Europe, and North America. The company offers Tacera, an IP nurse call system; Medicom, a solution for nurse call system; Pulse Mobile which allows staff to manage nurse call functions on the go and trigger workflows remotely; clinical workflow that allows healthcare staff to communicate with ancillary departments, measure adherence to protocol, and control other systems; Built-in RTLS, a nurse call platform; enterprise reporting; and integration services. It is also involved in the marketing, sales, and installation of electronic healthcare communication systems; and development of software and manufacture of hardware relating to healthcare and electronic communications systems. The company was formerly known as Azure Healthcare Limited and changed its name to Austco Healthcare Limited in November 2020. Austco Healthcare Limited was founded in 1986 and is headquartered in Port Melbourne, Australia.
Austco Healthcare Ltd management
2- Mr. Clayton AstlesCEO, MD & Executive Director
- Mr. Brendan James Maher ACA, BBusCFO & Company Secretary · born 1968